37159618|t|A Review of Biomarkers in Delirium Superimposed on Dementia (DSD) and Their Clinical Application to Personalized Treatment and Management.
37159618|a|Delirium superimposed on dementia (DSD) occurs when patients with pre-existing dementia develop delirium. This complication causes patients to become impaired, posing safety concerns for both hospital staff and patients. Furthermore, there is an increased risk of worsening functional disability and death. Despite medical advances, DSD provides both diagnostic and therapeutic challenges to providers. Identifying at-risk patients and providing personalized medicine and patient care can decrease disease burden in a time-efficient manner. This review delves into bioinformatics-based studies of DSD in order to design and implement a personalized medicine-based approach. Our findings suggest alternative medical treatment methods based on gene-gene interactions, gene-microRNA (miRNA) interactions, gene-drug interactions, and pharmacogenetic variants involved in dementia and psychiatric disorders. We identify 17 genes commonly associated with both dementia and delirium including apolipoprotein E (ApoE), brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase (COMT), butyrylcholinesterase (BChE), acetylcholinesterase (AChE), DNA methyltransferase 1 (DNMT1), prion protein (PrP), tumor necrosis factor (TNF), serine palmitoyltransferase long chain base subunit 1 (SPTLC1), microtubule-associated protein tau (MAPT), alpha-synuclein (alphaS), superoxide dismutase 1 (SOD1), amyloid beta precursor protein (APP), neurofilament light (NFL), neurofilament heavy, 5-hydroxytryptamine receptor 2A (HTR2A), and serpin family A member 3 (ERAP3). In addition, we identify six main genes that form an inner concentric model, as well as their associated miRNA. The FDA-approved medications that were found to be effective against the six main genes were identified. Furthermore, the PharmGKB database was used to identify variants of these six genes in order to suggest future treatment options. We also looked at previous research and evidence on biomarkers that could be used to detect DSD. According to research, there are three types of biomarkers that can be used depending on the stage of delirium. The pathological mechanisms underlying delirium are also discussed. This review will identify treatment and diagnostic options for personalized DSD management.
37159618	26	34	Delirium	Disease	MESH:D003693
37159618	51	59	Dementia	Disease	MESH:D003704
37159618	61	64	DSD	Disease	MESH:D003693
37159618	139	147	Delirium	Disease	MESH:D003693
37159618	164	172	dementia	Disease	MESH:D003704
37159618	174	177	DSD	Disease	MESH:D003693
37159618	191	199	patients	Species	9606
37159618	218	226	dementia	Disease	MESH:D003704
37159618	235	243	delirium	Disease	MESH:D003693
37159618	270	278	patients	Species	9606
37159618	350	358	patients	Species	9606
37159618	413	434	functional disability	Disease	MESH:D003291
37159618	439	444	death	Disease	MESH:D003643
37159618	472	475	DSD	Disease	MESH:D003693
37159618	562	570	patients	Species	9606
37159618	611	618	patient	Species	9606
37159618	736	739	DSD	Disease	MESH:D003693
37159618	1006	1014	dementia	Disease	MESH:D003704
37159618	1019	1040	psychiatric disorders	Disease	MESH:D001523
37159618	1093	1101	dementia	Disease	MESH:D003704
37159618	1106	1114	delirium	Disease	MESH:D003693
37159618	1125	1141	apolipoprotein E	Gene	348
37159618	1143	1147	ApoE	Gene	348
37159618	1150	1183	brain-derived neurotrophic factor	Gene	627
37159618	1185	1189	BDNF	Gene	627
37159618	1192	1220	catechol-O-methyltransferase	Gene	1312
37159618	1222	1226	COMT	Gene	1312
37159618	1229	1250	butyrylcholinesterase	Gene	590
37159618	1252	1256	BChE	Gene	590
37159618	1259	1279	acetylcholinesterase	Gene	43
37159618	1281	1285	AChE	Gene	43
37159618	1288	1311	DNA methyltransferase 1	Gene	1786
37159618	1313	1318	DNMT1	Gene	1786
37159618	1321	1334	prion protein	Gene	5621
37159618	1336	1339	PrP	Gene	5621
37159618	1342	1363	tumor necrosis factor	Gene	7124
37159618	1365	1368	TNF	Gene	7124
37159618	1371	1424	serine palmitoyltransferase long chain base subunit 1	Gene	10558
37159618	1426	1432	SPTLC1	Gene	10558
37159618	1435	1469	microtubule-associated protein tau	Gene	4137
37159618	1471	1475	MAPT	Gene	4137
37159618	1478	1493	alpha-synuclein	Gene	6622
37159618	1495	1501	alphaS	Gene	112935892
37159618	1504	1526	superoxide dismutase 1	Gene	6647
37159618	1528	1532	SOD1	Gene	6647
37159618	1535	1565	amyloid beta precursor protein	Gene	351
37159618	1573	1592	neurofilament light	Gene	4747
37159618	1594	1597	NFL	Gene	4747
37159618	1621	1652	5-hydroxytryptamine receptor 2A	Gene	3356
37159618	1654	1659	HTR2A	Gene	3356
37159618	1666	1690	serpin family A member 3	Gene	12
37159618	1777	1779	as	Gene	112935892
37159618	1785	1787	as	Gene	112935892
37159618	2139	2142	DSD	Disease	MESH:D003693
37159618	2246	2254	delirium	Disease	MESH:D003693
37159618	2295	2303	delirium	Disease	MESH:D003693
37159618	2400	2403	DSD	Disease	MESH:D003693
37159618	Association	MESH:D003704	590
37159618	Association	MESH:D003693	1786
37159618	Association	MESH:D003693	7124
37159618	Association	MESH:D003693	4137
37159618	Association	MESH:D003704	1786
37159618	Association	MESH:D003704	348
37159618	Association	MESH:D003693	590
37159618	Association	MESH:D003693	112935892
37159618	Association	MESH:D003693	627
37159618	Association	MESH:D003704	10558
37159618	Association	MESH:D003693	351
37159618	Association	MESH:D003693	6622
37159618	Association	MESH:D003704	7124
37159618	Association	MESH:D003704	627
37159618	Association	MESH:D003693	4747
37159618	Association	MESH:D003693	5621
37159618	Association	MESH:D003693	10558
37159618	Association	MESH:D003693	43
37159618	Association	MESH:D003693	12
37159618	Association	MESH:D003693	6647
37159618	Association	MESH:D003693	1312
37159618	Association	MESH:D003704	1312
37159618	Association	MESH:D003693	3356
37159618	Association	MESH:D003693	348

